Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Gaseous Nitric Oxide for Tinea Pedis
NCT00771342Phase 2Completed
- Sponsor
- Nitric BioTherapeutics
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Nitric oxide patch (Fundación Cardiovascular de Colombia) in tinea pedis (2 arms), sponsored by Nitric BioTherapeutics. Primary endpoints: Evidence of fungicidal activity at Day 26 and Clinical Symptom Severity Score at Day 26. Started Dec 2008; status: completed.
02
Drugs
Nitric oxide patch (Fundación Cardiovascular de Colombia)
03
Conditions
tinea pedis
Beyond the preview
Go deeper on NCT00771342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771342.